Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2022-10-18 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It fits the category of 'Transaction in Own Shares' which covers company buybacks or sales of its own shares. The document length is over 14,000 characters and contains detailed transactional data, confirming it is not a brief announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2022-10-18 English
Next Day Disclosure Returns
Regulatory Filings Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It is a formal regulatory filing required by the exchange to disclose share capital changes and buybacks. It does not contain financial statements, management discussion, or audit information. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2022-10-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on share repurchase activities, quantities, prices, and confirmations by company officers. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory disclosure about share capital changes and repurchases, fitting the description of a Transaction in Own Shares report rather than a full financial report or announcement of a report. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length and detail support a high confidence in this classification.
2022-10-14 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains detailed transactional data. The content fits the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2022-10-13 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data about share repurchases. The content fits the category of 'Transaction in Own Shares' (POS), which covers company buybacks or sales of its own shares.
2022-10-12 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on share repurchase transactions and confirmations related to these capital changes. There are no financial statements, earnings data, or management discussions. The document is a regulatory disclosure about share capital changes and repurchases, fitting the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares.
2022-10-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.